Petra Dieterich
Senior Vice President & Scientific Leader Abzena
Seminars
Wednesday 14th October 2026
Leveraging Bioconjugation Strategies to Enhance AOC CMC Processes
9:30 am
- Navigating the nuances of oligonucleotide conjugate process development and understanding how to leverage physiochemical properties and chemistry aspects between different AOCs
- Comparing AOCs with classical ADCs: Explore payload complexity, impurity profiles, and essential analytical methods
- Assessing the evolving regulatory framework, impurity control, stability, immunogenicity and target product profiles
- Spotlighting real-world customer case studies that demonstrate a risk-managed approach to get to the clinic quicker
